Chenfei Chi
Publications by Year
Research Areas
Prostate Cancer Treatment and Research, Prostate Cancer Diagnosis and Treatment, Radiopharmaceutical Chemistry and Applications, Cancer, Lipids, and Metabolism, Cancer-related molecular mechanisms research
Most-Cited Works
- → Systemic immune‐inflammation index predicts the combined clinical outcome after sequential therapy with abiraterone and docetaxel for metastatic castration‐resistant prostate cancer patients(2017)61 cited
- → PRKAR2B promotes prostate cancer metastasis by activating Wnt/β‐catenin and inducing epithelial‐mesenchymal transition(2018)57 cited
- → PRKAR2B‐HIF‐1α loop promotes aerobic glycolysis and tumour growth in prostate cancer(2020)57 cited
- → Transcriptional regulation of PRKAR2B by miR-200b-3p/200c-3p and XBP1 in human prostate cancer(2020)55 cited
- → Prognostic nutritional index predicts initial response to treatment and prognosis in metastatic castration‐resistant prostate cancer patients treated with abiraterone(2017)41 cited
- → The Microbiome of Prostate Fluid Is Associated With Prostate Cancer(2019)39 cited
- → Upregulated KDM4B promotes prostate cancer cell proliferation by activating autophagy(2019)39 cited
- → Use of Circulating Tumor DNA for the Clinical Management of Metastatic Castration-Resistant Prostate Cancer: A Multicenter, Real-World Study(2021)38 cited
- → Comparative Analysis of Genomic Alterations across Castration Sensitive and Castration Resistant Prostate Cancer via Circulating Tumor DNA Sequencing(2020)36 cited
- → Neoadjuvant chemohormonal therapy combined with radical prostatectomy and extended PLND for very high risk locally advanced prostate cancer: A retrospective comparative study(2019)35 cited